Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

MycoMeditations Celebrates 10 Years of Psilocybin Therapy Retreats


News provided by

MycoMeditations

Apr 29, 2024, 08:00 ET

Share this article

Share toX

Share this article

Share toX

MycoMeditations staff celebrate 10 years of psilocybin retreats.
MycoMeditations staff celebrate 10 years of psilocybin retreats.

A decade of innovation, healing, and leadership in Jamaica

TREASURE BEACH, Jamaica, April 29, 2024 /PRNewswire-PRWeb/ -- MycoMeditations, Jamaica's longest-running legal psilocybin-assisted therapy retreat company, is proud to announce its 10th anniversary of providing life-changing psychedelic experiences. Since its founding in 2014, MycoMeditations has been at the forefront of the psychedelic renaissance, offering safe, legal, and science-based psilocybin retreats to individuals seeking healing, personal growth, and spiritual exploration.

Over the past decade, MycoMeditations has:

I wonder how the trajectory of my life might have been different had I experienced such a life-altering week as a young adult.

Post this
  • Served over 2,000 guests more than 6,000 doses of psilocybin
  • Published compelling data on the efficacy of its retreat protocol for treating PTSD as well as depression and anxiety
  • Assembled a world-class team of licensed clinicians and experienced facilitators
  • Consulted with the Jamaican government to develop standards for psilocybin in Jamaica
  • Established itself as a trusted leader in the global conversation around psychedelic medicine

"As we celebrate this milestone, we reflect on the profound impact our work has had on the lives of our guests," said Justin Townsend, CEO and Head Facilitator of MycoMeditations. "We are honored to have played a role in the psychedelic renaissance and to have helped so many individuals find healing and transformation through psilocybin-assisted therapy."

MycoMeditations' success is rooted in its commitment to a scientific, evidence-based approach to psilocybin retreats. The company's unique protocols, which combine multiple high-dose psilocybin sessions with comprehensive preparation and integration support, have consistently delivered measurable improvements in mental health outcomes.

"Our retreat model is designed to maximize the therapeutic potential of psilocybin while prioritizing the safety and well-being of our guests," said Townsend. "We believe that the combination of experienced facilitators, personalized therapeutic attention, group work, and a structured approach is key to unlocking the transformative power of psychedelics."

As the demand for psychedelic therapies continues to grow, MycoMeditations is well-positioned to serve a diverse range of individuals, from Baby Boomers and retirees seeking renewed purpose and vitality, to entrepreneurs and high net worth individuals looking to optimize their performance and well-being.

"We've seen a significant increase in interest from older adults and professionals who are drawn to the idea of a more intentional, curated psychedelic experience," said Townsend. "Our retreats offer a safe, immersive environment for these individuals to explore the benefits of psilocybin and to catalyze profound personal and professional growth."

"I have been in psychotherapy or some kind of healing modality since 1993 yet at 65 years old, I still found myself struggling to stay well, work successfully and engage with others deeply. My sessions at MycoMeditations were somehow able to release deeply repressed trauma that I have never been able to access in any other healing modality," said Suzi, another guest.

"As a retired mental health professional, I approached MycoMeditations with a wary eye and an appreciation for the differences between psilocybin-assisted therapy and the traditions of Western medicine. I feel strongly now that the use of psilocybin under the carefully considered protocol that MycoMeditations has designed promises breakthroughs in treatment of anxiety, depression, and PTSD," said Paul, a recent guest.

MycoMeditations guest Steven reflected: "I wonder how the trajectory of my life might have been different had I experienced such a life-altering week as a young adult. In response to this thought, I have offered each of my adult children to do this retreat at any time, on my dime."

Looking ahead, MycoMeditations remains committed to advancing the science and practice of psilocybin-assisted therapy, and to advocating for the responsible integration of psychedelics into modern healthcare.

"We believe that psychedelic medicines have the potential to revolutionize the way we approach mental health and well-being," said Townsend. "As we celebrate our first decade, we are more inspired than ever to continue our mission of bringing these transformative experiences to those who can benefit from them."

For more information about MycoMeditations and its upcoming retreats, visit mycomeditations.com.

Media Contact

Brad Burge, MycoMeditations, 1 6508636887, brad@integrationcommunications.com, http://mycomeditations.com 

SOURCE MycoMeditations

Modal title

MycoMeditations has been providing legal psilocybin retreats since 2014.
MycoMeditations has been providing legal psilocybin retreats since 2014.
Dried psilocybin mushrooms.
Dried psilocybin mushrooms.
MycoMeditations Lead Facilitator and CEO Justin Townsend leads a group integration.
MycoMeditations Lead Facilitator and CEO Justin Townsend leads a group integration.
MycoMeditations offers psilocybin retreats in a serene, natural environment.
MycoMeditations offers psilocybin retreats in a serene, natural environment.
MycoMeditations offers best-in-class facilities for its psilocybin-assisted therapy retreat programs.
MycoMeditations offers best-in-class facilities for its psilocybin-assisted therapy retreat programs.
MycoMeditations has been providing legal psilocybin retreats since 2014. Dried psilocybin mushrooms. MycoMeditations Lead Facilitator and CEO Justin Townsend leads a group integration. MycoMeditations offers psilocybin retreats in a serene, natural environment. MycoMeditations offers best-in-class facilities for its psilocybin-assisted therapy retreat programs.

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.